Xeris Biopharma Holdings, Inc. (XERS)

NASDAQ: XERS · Real-Time Price · USD

8.60

-0.20 (-2.27%)

At close: Jul 20, 2026, 4:00 PM EDT

8.63

+0.03 (0.35%)

Pre-market: Jul 21, 2026, 4:32 AM EDT

Xeris Biopharma Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	12.01	0.55	-54.84	-62.26	-94.66	-122.73
Depreciation & Amortization	12.18	12.16	12.07	12.33	12.24	1.88
Stock-Based Compensation	22.06	22.37	18.36	10.72	12.16	11.38
Other Adjustments	4	3.91	-3.76	-1.52	2.52	2.08
Change in Receivables	-9.97	-10.64	-1.22	-8.37	-13.37	-6.24
Changes in Inventories	-14.82	-19.29	-8.78	-14.8	-7.47	-7.42
Changes in Accounts Payable	0.12	-0.07	-9.61	6.96	-4.32	5.53
Changes in Accrued Expenses	10.39	3.31	3.65	-5.86	-11.38	12.56
Changes in Other Operating Activities	12.55	16.32	7.14	15.77	1.39	7.43
Operating Cash Flow	48.53	28.63	-36.98	-47.02	-102.89	-95.54
Capital Expenditures	-1.01	-0.7	-0.87	-2.26	-0.52	-1.09
Purchases of Investments	-	-	-34.49	-43.74	-	-43.02
Proceeds from Sale of Investments	-	-	40.24	40	34.99	103.6
Other Investing Activities	-	-	-	-	-	38.47
Investing Cash Flow	-1.01	-0.7	4.88	-6	34.46	97.96
Long-Term Debt Issued	-	-	50	-	146.21	-
Long-Term Debt Repaid	-	-	-	-	-43.5	-
Net Long-Term Debt Issued (Repaid)	-	-	50	-	102.72	-
Issuance of Common Stock	7.56	22.27	1.73	0.58	30.84	27.84
Repurchase of Common Stock	-19.9	-10.88	-3.73	-1.01	-0.47	-0.53
Net Common Stock Issued (Repurchased)	-12.33	11.39	-2	-0.43	30.37	27.3
Other Financing Activities	-	-	-11.83	-1.19	-5.61	-0.05
Financing Cash Flow	5.69	11.39	36.17	-1.61	127.47	27.25
Effect of Exchange Rate Changes on Cash and Cash Equivalents	-	-	-	-	-	-0
Net Cash Flow	53.21	39.32	4.07	-54.64	59.04	29.67
Free Cash Flow	47.52	27.93	-37.85	-49.29	-103.42	-96.62
Free Cash Flow Growth	70.14%	-	-	-	-	-
FCF Margin	15.09%	9.57%	-18.64%	-30.07%	-93.80%	-194.84%
Free Cash Flow Per Share	0.27	0.16	-0.26	-0.36	-0.76	-1.22
Levered Free Cash Flow	31.42	12.29	-1.24	-50.12	-2	-103.84
Unlevered Free Cash Flow	55.32	36.63	-28.71	-31	-90.78	-96.27

SEC Filings: 10-K · 10-Q